Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
Hong Kong · Delayed Price · Currency is HKD 20.00
-0.35 (-1.72%)
Jul 29, 2025, 9:44 AM HKT
HKG:2252 Revenue
In the year 2024, Shanghai MicroPort MedBot (Group) had annual revenue of 257.25M CNY with 145.95% growth. Shanghai MicroPort MedBot (Group) had revenue of 158.01M in the half year ending December 31, 2024, with 668.73% growth.
Revenue
257.25M CNY
Revenue Growth
+145.95%
P/S Ratio
76.17
Revenue / Employee
580.70K CNY
Employees
443
Market Cap
20.85B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 257.25M | 152.66M | 145.95% |
| Dec 31, 2023 | 104.59M | 82.99M | 384.15% |
| Dec 31, 2022 | 21.60M | 19.45M | 904.79% |
| Dec 31, 2021 | 2.15M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |